Sunrest Lifescience Dissolves Rights Issue After Minimum Subscription Shortfall

Board dissolved the rights issue per Letter of Offer dated Aug 7, 2026 due to non-receipt of minimum subscription; issue open Aug 18-Sep 2, extended to Sep 11, applicant funds to be unblocked. Cancellation under SEBI ICDR Regulation 86 after undersubscription; planned capital raise fails, signalling weak investor demand for the issue. Company will not receive rights proceeds, leaving funding plans unmet; focus shifts to alternative fundraising or operations with no dilution from this issue.